<DOC>
	<DOCNO>NCT01206270</DOCNO>
	<brief_summary>Patients infertility often present alteration ultrasonographic examination testis . These alteration include much high incidence small , multiple , non-palpable hypoechoic micro-nodules show internal vascularization . This find often create alarm anxiety , place differential diagnosis versus low-stage malignant germ cell tumor . Nevertheless , explorative surgery reveal consistent number lesion benign , due Leydig cell hyperplasia Leydig cell tumour . The purpose study evaluate effect androgen therapy size number non-palpable hypoechoic micro-nodules patient elevate gonadotropin level .</brief_summary>
	<brief_title>Androgen Leydig Cell Proliferation</brief_title>
	<detailed_description>Patients testicular dysgenesis syndrome , comprise variable spectrum clinical manifestation , infertility , cryptorchidism , hypospadias , impaired spermatogenesis testicular germ cell neoplasm , often develop alteration Leydig cell compartment . These alteration range abnormal localization cluster hyperplasia tumorous formation . Leydig cell tumor ( LCTs ) , although uncommon general population , frequent non-germ cell testicular neoplasm , incidence report increasingly grow , especially infertile patient . Given focal area Leydig cell hyperplasia nowadays easily detectable ultrasonography testis ( US ) , small non-palpable hypoechoic micro-nodules show internal vascularization , find create diagnostic challenge versus low-stage malignant germ cell tumor . Patients testicular dysgenesis syndrome general exhibit elevation Follicle-Stimulating Hormone ( FSH ) , patient , frequently , even Luteinizing Hormone ( LH ) reference range . The latter work growth factor Leydig cell . Since exogenous testosterone suppress LH level , could androgen therapy could revert LH-induced growth stimulation Leydig cell compartment . The purpose study evaluate effect androgen therapy size number non-palpable hypoechoic micro-nodules patient elevate gonadotropin level . The purpose study also evaluate whether behavior ( UltraSonographic appearance , US ) non-palpable hypoechoic micro-nodules 4-month trial testosterone therapy offer novel diagnostic tool differential diagnosis benign versus malignant testicular nodule . The trial open patient multiple non-palpable hypoechoic micro-nodules elevation FSH LH seek conception . Participants study randomized one two treatment group , receive either testosterone undecanoate ( low-dose androgen ) placebo , two 6 month . All participant evaluate safety begin study 2 , 4 , 6 month careful history , physical examination , blood sample testicular ultrasonography . Patients also offer possibility perform Magnetic Resonance Imaging ( MRI ) testis baseline treatment , and/or surgical enucleation lesion .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Azoospermia</mesh_term>
	<mesh_term>Klinefelter Syndrome</mesh_term>
	<mesh_term>Castor Oil</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Nonpalpable Multiple hypoechoic testicular nodule ( large diameter &gt; 2 mm &lt; 12 mm ) Serum Folliclestimulating hormone ( FSH ) &gt; 7 mIU/ml ( mInternationalUnit/ml ) Serum Luteinizing hormone ( LH ) &gt; 7 UI ( mInternationalUnit/ml ) Infertility : Klinefelter Syndrome , Hypergonadotropic Hypogonadism , Hypergonadotropic Azospermia , Hypergonadotropic Cryptozoospermia negative testicular tumor marker : betahCG ( Human chorionic gonadotropin ) , alphaFP ( FetoProtein ) , CEA ( Carcinoembryonic antigen ) , LDH ( Lactate dehydrogenase ) , ferritin , PLAP ( Placental Alkaline Phosphatase ) . Hypogonadotropic Hypogonadism FSH LH &lt; 7 UI nonhomogeneous testicular lesion &gt; 12 mm positive testicular tumor marker : betahCG , alphaFP , CEA , LDH , ferritin , PLAP patient contraindication testosterone therapy : prostate cancer , PSA &gt; 4 ng/ml , severe hepatic renal insufficiency , Hb &gt; 17 , Htc &gt; 52 % , severe urinary retention desire conceive history germcell testicular neoplasia</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Klinefelter</keyword>
	<keyword>Leydig</keyword>
	<keyword>Testicular Tumor</keyword>
	<keyword>LH</keyword>
	<keyword>Infertility</keyword>
</DOC>